Industry Verticals »

All Categories

Insights »

About TMR »

Neuromodulation Devices Market

Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018

Global Neuromodulation Devices Market: Analyst’s Estimations

Although a relatively new therapy pertaining to the nervous systems – neuromodulation has evolved consistently in the recent past, enabling in altering nerve activities via targeted stimulus delivery such as chemical agents or electrical stimulation. Neuromodulation has proven its worth for the diagnosis of various ubiquitous chronic diseases such as depression and Alzheimer’s disease. On the back of the trend of minimally invasive procedures, the demand for devices that are used for neuromodulation is primed to proliferate. According to the findings of this business intelligence report, the global neuromodulation devices market will be worth US$7.0 billion by the end of 2018, with the demand expanding at a striking CAGR of 14.40% during the forecast period of 2012 to 2018.

Apart from the growing prevalence of neurological disorders, the neuromodulation devices market is gaining traction from increasing population of geriatrics, promising product pipeline, influx of investments from public and private bodies, and expanding application with new indications. On the other hand, lack of trained professionals and poor reimbursement policies in several emerging economies is obstructing the market from flourishing.

The analyst of the report, a healthcare expert with vast experience in researching the commerce of the field, has provided in-depth assessment of the factors that will determine the demand for neuromodulation devices in the near future. The report also contains market segmentations on the basis of technology and application as well as showcases demand potential of every important region and country across the globe. It concludes with a featured chapter on the competitive landscape, wherein a number of prominent companies of this market have been evaluated and analyzed for their shares and recent business decisions.

Spinal Cord Stimulation Key Technology Segment

Technology-wise, the market for neuromodulation devices has been segmented into gastric electric stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, deep brain stimulation devices, and spinal cord stimulation medical devices. In the near future, spinal cord stimulation segment is expected to make strong profits as it is used in the treatment of various chronic pain. The FDA has recently given approvals to a number of spinal cord stimulation technologies, such as St. Jude Medical’s Proclaim Elite SCS and Nervo Corporation’s Senza SCS system. Some of the newer indications that are supported by SCS are refractory angina pectorsis, failed back surgery syndrome, and complex regional pain syndrome. That being said, the analyst of the report has foreseen the deep brain stimulation (DBS) segment to expand at a stronger growth rate, feeding off new indications such as treatment resistant depression, obsessive compulsive disorder, and Alzheimer’s type dementia.

Technology-wise, the neuromodulation devices market has been bifurcated into Boston Scientific’s Precision Spinal Cord Stimulation System, Jude Medical’s Eon Mini Neurostimulator System, Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems, Codman & Shurtleff’s Medstream System, Cyberonics’ VNS Therapy System, Nevro’s Senza System for Spinal Cord Stimulation, IntraPace’s Abiliti System, and Medtronic’s Enterra Therapy System.

The U.S. Remains Key Country-wide Market

Geographically, North America continues to be the region with maximum demand potential, which primarily comes from the U.S. As of 2018, North America accounts for well over half of the total demand for neuromodulation devices, which can also be attributed to strong prevalence of depression and other chronic pains across the increasing geriatric population. However, Asia Pacific is another region with great potential owing to its large population base, constituted by the emerging economies of China and India.

St. Jude Medical, Medtronic, Cyberonics, Nevro, Boston Scientific Group, Codman and Shurtleff, Integra, Cervel Neurotech Inc., Uroplasty, IntraPace, and Neuronetics Inc. are some of the key companies currently ahead of the curve in the global neuromodulation devices market.

     

    CHAPTER 1 PREFACE

    1.1 REPORT DESCRIPTION

    1.2 RESEARCH METHODOLOGY

     

    CHAPTER 2 EXECUTIVE SUMMARY

     

    CHAPTER 3 MARKET OVERVIEW

    3.1 MARKET DYNAMICS

          3.1.1 DRIVERS

                  3.1.1.1 Aging population inducing chronic diseases such as Parkinson’s and Alzheimer’s disorders

                  3.1.1.2 Technological advancements

                  3.1.1.3 Rising prevalence of chronic diseases and the presence of unmet medical needs

                  3.1.1.4 Add on therapy nature of neuromodulation devices

                  3.1.1.5 Increasing demand for minimally invasive surgeries

                  3.1.1.6 Rising healthcare related consumer expenditure

                  3.1.1.7 Rising instances of external funding to conduct clinical studies

                  3.1.1.8 Increasing global prevalence of lifestyle induced illnesses such as depression and obesity

          3.1.2 IMPACT ANALYSIS OF DRIVERS

          3.1.3 RESTRAINTS

                  3.1.3.1 Side effects and risks associated with the use of a neuromodulation  device

                  3.1.3.2 FDA approvals and other government regulations

                             3.1.3.2.1 Affordable Healthcare for America Act, 2010

                  3.1.3.3 Rapidly changing technologies

                  3.1.3.4 Availability of alternate treatment procedures

         3.1.4 NEURMODULATION DEVICES MARKET RESTRAINTS IMPACT ANALYSIS

         3.1.5 OPPORTUNITIES

                  3.1.5.1 Emerging economies in Asia, Latin America and Eastern European countries

                  3.1.5.2 Medical device manufacture outsourcing

                  3.1.5.3 Increasing clarity pursuant to the human nervous system

                  3.1.5.4 Consolidation opportunities in the healthcare industry

          3.1.6 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

    3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

          3.2.1 BARGAINING POWER OF SUPPLIERS

          3.2.2 BARGAINING POWER OF BUYERS

          3.2.3 THREAT OF NEW ENTRANTS

          3.2.4 THREAT OF SUBSTITUTES

          3.2.5 COMPETITIVE RIVALRY

    3.3 MARKET ATTRACTIVENESS ANALYSIS

          3.3.1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

          3.3.2 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

                  3.3.2.1 Emerging and Future Market Trends by Technology

     

    CHAPTER 4 NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

    4.1 OVERVIEW

           4.1.1 GLOBAL NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

           4.1.2 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018

    4.2 SPINAL CORD STIMULATION DEVICES

           4.2.1 INTRODUCTION

           4.2.2 MARKET SIZE AND FORECAST

    4.3 DEEP BRAIN STIMULATION DEVICES

           4.3.1 INTRODUCTION

           4.3.2 MARKET SIZE AND FORECAST

    4.4 SACRAL NERVE STIMULATION DEVICES

           4.4.1 INTRODUCTION

           4.4.2 MARKET SIZE AND FORECAST

    4.5 VAGUS NERVE STIMULATION DEVICES

           4.5.1 INTRODUCTION

           4.5.2 MARKET SIZE AND FORECAST

    4.6 GASTRIC ELECTRIC STIMULATION DEVICES

           4.6.1 INTRODUCTION

           4.6.2 MARKET SIZE AND FORECAST

     

    CHAPTER 5 NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

    5.1 OVERVIEW

    5.2 NORTH AMERICA

           5.2.1 MARKET OVERVIEW

           5.2.1 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

           5.2.2 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

           5.2.3 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET

           5.2.4 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET

           5.2.5 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET

           5.2.6 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET

           5.2.7 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET

    5.3 EUROPE

           5.3.1 MARKET OVERVIEW

           5.3.2 EUROPE NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

           5.3.3 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

           5.3.4 EUROPE SPINAL CORD STIMULATION DEVICES MARKET

           5.3.5 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET

           5.3.6 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET

           5.3.7 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET

           5.3.8 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET

    5.4 ASIA PACIFIC

           5.4.1 MARKET OVERVIEW

           5.4.1 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

           5.4.2 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018

           5.4.3 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET

           5.4.4 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET

           5.4.5 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET

           5.4.6 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET

           5.4.7 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET

    5.5 REST OF THE WORLD

           5.5.1 MARKET OVERVIEW

           5.5.1 R.O.W NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

           5.5.2 ROW NEUROMODULATION DEVICES MARKET BY VOLUME, NO. OF UNITS, 2011 – 2018

           5.5.3 R.O.W SPINAL CORD STIMULATION DEVICES MARKET

           5.5.4 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET

           5.5.5 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET

           5.5.6 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET

           5.5.7 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET

     

    CHAPTER 6 COMPETITIVE LANDSCAPE

    6.1 MARKET SHARE BY KEY PLAYERS

    6.2 COMPETITIVE STRATEGIES BY KEY PLAYERS

           6.2.1 MARKET LEADERS

           6.2.2 NEW ENTRANTS

     

    CHAPTER 7 RECOMMENDATIONS

    7.1 MARKET STRATEGY FOR SUCCESS

    7.2 BARRIERS TO BE CONSIDERED

     

    CHAPTER 8 COMPANY PROFILES

    8.1 KEY  PLAYERS

           8.1.1 MEDTRONIC

                   8.1.1.1 Company Overview

                   8.1.1.2 Business Strategies

                   8.1.1.4 Financial Overview

                   8.1.1.5 Product Portfolio

                   8.1.1.6 Recent Developments

          8.1.2 ST. JUDE MEDICAL

                   8.1.2.1 Company Overview

                   8.1.2.2 Business Strategies

                   8.1.2.4 Financial Overview

                   8.1.2.5 Product Portfolio

                   8.1.2.6 Recent Developments

          8.1.3 BOSTON SCIENTIFIC

                   8.1.3.1 Company Overview

                   8.1.3.2 Business Strategies

                   8.1.3.4 Financial Overview

                   8.1.3.5 Product Portfolio

                   8.1.3.6 Recent Developments

          8.1.4 CYBERONICS

                   8.1.4.1 Company Overview

                   8.1.4.2 Business Strategies

                   8.1.4.3 Financial Overview

                   8.1.4.4 Product Portfolio

                   8.1.4.5 Recent Developments

          8.1.5 NEVRO

                   8.1.5.1 Company Overview

                   8.1.5.2 Business Strategies

                   8.1.5.3 Financial Overview

                   8.1.5.4 Product Portfolio

                   8.1.5.5 Recent Developments

    8.2 NEW ENTRANTS

          8.2.1 NEURONETICS, INC.

                   8.2.1.1 Company Overview

                   8.2.1.2 Business Strategies

                   8.2.1.3 Financial Overview

                   8.2.1.4 Product Portfolio

                   8.2.1.5 Recent Developments

          8.2.2 UROPLASTY

                   8.2.2.1 Company Overview

                   8.2.2.2 Business Strategies

                   8.2.2.3 Financial Overview

                   8.2.2.4 Product Portfolio

                   8.2.2.5 Recent Developments

    TABLE OF CONTENTS

     

    TABLE 1 GLOBAL NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 – 2018 (USD MILLION)

    TABLE 2 IMPACT ANALYSIS OF DRIVERS

    TABLE 3 IMPACT ANALYSIS OF RESTRAINTS

    TABLE 4 EMERGING AND FUTURE MARKET TRENDS BY TECHNOLOGY

    TABLE 5 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 6 PRODUCTS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SPINAL CORD STIMULATION DEVICES MARKET

    TABLE 7 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

    TABLE 8 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 9 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE DEEP BRAIN STIMULATION DEVICES MARKET

    TABLE 10 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

    TABLE 11 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 12 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SACRAL NERVE STIMULATION DEVICES MARKET

    TABLE 13 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

    TABLE 14 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 15 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE VAGUS NERVE STIMULATION DEVICES MARKET

    TABLE 16 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

    TABLE 17 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 18 GLOBAL GASTRIC ELCTRIC STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

    TABLE 19 GLOBAL GASTRIC ELECTRIC STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 20 NORTH AMERICA NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

    TABLE 21 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 22 EUROPE NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

    TABLE 23 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 24 ASIA PACIFIC NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

    TABLE 25 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

    TABLE 26 R.O.W NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

    TABLE 27 R.O.W NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

    LIST OF FIGURES

     

    FIG. 1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

    FIG. 2 HEALTHCARE RELATED CONSUMER EXPENDITURE IN JAPAN, U.S., GERMANY AND CANADA, 2008 TO 2010 (USD  MILLION)

    FIG. 3 HEALTHCARE RELATED CONSUMER EXPENDITURE IN BRAZIL, INDIA AND CHINA, 2008 TO 2010 (USD  MILLION)

    FIG. 4 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES  MARKET

    FIG. 5 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

    FIG. 6 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

    FIG. 7 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

    FIG. 8 COMPARITIVE ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

    FIG. 9 GLOBAL NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 10 GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 11 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 12 GLOBAL SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 13 GLOBAL VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 14 GLOBAL GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 15 COMPARATIVE ANALYSIS OF THE NEUROMODULATION DEVICES MARKET BY GEOGRAPHY, 2011 & 2018 (%)

    FIG. 16 COMPARATIVE ANALYSIS OF THE NORTH AMERICAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

    FIG. 17 NORTH AMERICA NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 18 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 19 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 20 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 21 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 22 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 23 COMPARATIVE ANALYSIS OF THE EUROPEAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

    FIG. 24 EUROPE NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 25 EUROPE SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 26 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 27 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 28 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 29 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 30 COMPARATIVE ANALYSIS OF THE ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

    FIG. 31 ASIA PACIFIC NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 32 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 33 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 34 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 35 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 36 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 37 COMPARITIVE ANALYSIS OF THE R.O.W NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

    FIG. 38 R.O.W NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 39 R.O.W SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 40 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 41 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 42 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 43 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

    FIG. 44 MARKET SHARE BY KEY PLAYERS, 2011 (%)

    FIG. 45 SWOT ANALYSIS OF MEDTRONIC

    FIG. 46 ANNUAL REVENUE (USD MILLION) OF MEDTRONIC, 2008 - 2011

    FIG. 47 SWOT ANALYSIS OF ST. JUDE MEDICAL

    FIG. 48 ANNUAL REVENUE (USD MILLION) OF ST. JUDE MEDICAL, 2008 - 2011

    FIG. 49 SWOT ANALYSIS OF BOSTON SCIENTIFIC GROUP

    FIG. 50 ANNUAL REVENUE (USD MILLION) OF BOSTON SCIENTIFIC GROUP, 2008 - 2011

    FIG. 51 ANNUAL REVENUE (USD MILLION) OF CYBERONICS, 2008 - 2011

    FIG. 52 ANNUAL REVENUE (USD MILLION) OF UROPLASTY, 2008 - 2011

Copyright © Transparency Market Research, Inc. All Rights reserved

Neuromodulation Devices Market

Schedule a Call